Cell Secretome: Basic Insights and Therapeutic Opportunities for CNS Disorders
Open accessThe DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Abstract
Transplantation of stem cells, in particular mesenchymal stem cells (MSCs), stands as a promising therapy for trauma, stroke or neurodegenerative conditions such as spinal cord or traumatic brain injuries (SCI or TBI), ischemic stroke (IS), or Parkinson’s disease (PD). Over the last few years, cell transplantation-based approaches have started to focus on the use of cell byproducts, with a strong emphasis on cell secretome. Having this in mind, the present review discusses the current state of the art of secretome-based therapy applications in different central nervous system (CNS) pathologies. For this purpose, the following topics are discussed: (1) What are the main cell secretome sources, composition, and associated collection techniques; (2) Possible differences of the therapeutic potential of the protein and vesicular fraction of the secretome; and (3) Impact of the cell secretome on CNS-related problems such as SCI, TBI, IS, and PD. With this, we aim to clarify some of the main questions that currently exist in the field of secretome-based therapies and consequently gain new knowledge that may help in the clinical application of secretome in CNS disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Number of publications per year of cell-, secretome-, or exosome-based therapies on central nervous system (CNS) disorders (Parkinson’s disease (PD), spinal cord injury (SCI), traumatic brain injury (TBI) and ischemic stroke (IS)). An electronic research on PubMed database for literature describing cell-, secretome-, and exosome-based therapies was performed on 18 January 2019 using the following keywords: (cell OR cellular OR stem OR cells) AND (transplantation OR transplant OR “Co-Transplantation” OR Cotransplantation OR engraft OR engraftment OR graft OR grafts) AND (therapy OR therapies OR therapeutics OR therapeutic) NOT Review [Publication Type] AND (“spinal cord injury” or “brain injury” or stroke or parkinson) AND (primates OR mice OR mouse OR rat OR rats OR rodent OR “in vivo” OR “clinical Trials” OR humans) for cell-based therapies and (conditioned medium OR conditioned media OR secretory OR “trophic factors” OR Exosomes OR vesicles OR microvesicles OR vesicular OR “Extracellular vesicles” OR “nanovesicles” OR “exosomal”) AND (therapy OR therapies OR therapeutics OR therapeutic) NOT Review[Publication Type] AND (“spinal cord injury” or “brain injury” or stroke or parkinson) AND (primates OR mice OR mouse OR rat OR rats OR rodent OR “in vivo” OR “clinical Trials” OR humans) for secretome- and exosome-based therapies. The search retrieved 3676 articles for cell-based therapies and 682 articles for secretome- and exosome-based therapies. Data extraction was independently performed by two researchers.](https://figures.cochat.ai/paper-figures/a37d098deb8648058a26f97d504e4a48/cell-secretome-basic-insights-and-therapeutic-opportunities-for-cns-disorders-figure-1.jpg)
![Figure 2 Mesenchymal stem cell secretome composition and their main effects on the CNS. On their soluble fraction (red circles), MSC secretome contains cytokines, chemokines, growth factors, and glycoproteins. On their vesicular fractions (orange circles), the exosomes and microvesicles contain essentially microRNAs. Both the soluble and the vesicular fractions may act on distinct damaged cells of the nervous system, promoting their survival, angiogenesis, neurite outgrowth, and immunomodulation. This information is based on the articles [85,86].](https://figures.cochat.ai/paper-figures/6a9797bee1d545a395bd5dd96ec7519b/cell-secretome-basic-insights-and-therapeutic-opportunities-for-cns-disorders-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It involves the in vitro modulation of the secretome produced by MSC by exposing these cells to specific factors that usually mimic the tissue damage microenvironment [73], namely to hypoxia, inflammatory or disease-specific cytokines and/or pharmacological compounds, or even by using 3-dimensional (3D) cell culture systems [54], [120], [121].”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [54]
The cited source says what the claim attributes to it.
In the citing paper
“Multiple studies exploring strategies of modulating environmental factors with the potential to enhance the beneficial effects of secretome-contained biomolecules have been performed, namely via preconditioning [18], [54], [120].”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Biological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926 · cited 1×
“biologic content on cell cytoplasm, finally inducing angiogenesis [91,92] and neurite outgrowth [93,94] and regulating inflammatory responses [95,96].”
BackgroundMathieu, M., Martin-Jaular, L., Lavieu, G., & Théry, C. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0250-9 · Cited by 3,737 · cited 1×
“However, the vesicular fraction by itself could also constitute a powerful therapeutic approach since EVs are similarly involved in intercellular communication and may contain all the signals required for a successful contact [101].”
BackgroundEstimating the global incidence of traumatic brain injury
Dewan, M. C., Rattani, A., Gupta, S., Baticulon, R. E., Hung, Y.-C., Punchak, M., Agrawal, A., Adeleye, A. O., Shrime, M. G., Rubiano, A. M., et al. (2019) · Journal of Neurosurgery · doi:10.3171/2017.10.jns17352 · Cited by 3,291
Regeneration beyond the glial scar
Silver, J., & Miller, J. H. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1326 · Cited by 3,078 · cited 1×
“, cellular dysfunction or death, overactivation of immune cells, production of reactive oxygen species or proteoglycans, and glial scar formation) that exacerbate the primary insult [9,10].”
BackgroundMesenchymal stem cells as trophic mediators
Caplan, A. I., & Dennis, J. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20886 · Cited by 2,992 · cited 1×
“Indeed, factors such as GDNF, NGF, HGF, VEGF, IGF-1 and 2, chemokine (C-X-C motif) ligand (CXCL 16), IL-6 and 10, TGF β1, and MCP-1 have been related to the neuro- and immunoregulatory character of MSC secretome [63,87,99,100].”
BackgroundSecretion of angiogenic and antiapoptotic factors by human adipose stromal cells
Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., Temm-Grove, C. J., Bovenkerk, J. E., Pell, C. L., Johnstone, B. H., Considine, R. V., & March, K. L. (2004) · Circulation · doi:10.1161/01.cir.0000121425.42966.f1 · Cited by 2,269 · cited 1×
“Similarly to what has been reported for BM-MSCs, growth factors such as vascular endothelial growth factor (VEGF), glial-derived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF), hepatocyte growth factor (HGF), fibroblast growth factor (FGF), nerve growth factor (NGF), insulin-like growth factors 1…”
BackgroundThe prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188
Exosomes as drug delivery vehicles for Parkinson’s disease therapy
Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R., Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A. V., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.033 · Cited by 2,009
Vlassov, A. V., Magdaleno, S., Setterquist, R., & Conrad, R. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.03.017 · Cited by 1,930 · cited 1×
“, messenger RNAs and microRNAs) and small proteins are secreted through membranal fusion to the extracellular space [89,90].”
BackgroundPosition statement: definition of traumatic brain injury
Menon, D. K., Schwab, K., Wright, D. W., & Maas, A. I. (2010) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2010.05.017 · Cited by 1,678
Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., et al. (2005) · Nature Medicine · doi:10.1038/nm0405-367 · Cited by 1,677
Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo
Jin, K., Zhu, Y., Sun, Y., Mao, X. O., Xie, L., & Greenberg, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182296499 · Cited by 1,507 · cited 1×
“Importantly, on the nervous system, VEGF could be associated with neurogenesis [65,66], neuromaturation [67], neuroprotection [68,69], and even neuroregeneration [70].”
BackgroundMesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine
Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091852 · Cited by 1,363 · cited 2×
“Currently, this definition could be updated since it is known that, beyond soluble factors, the secretome also has the presence of lipids and extracellular vesicles (EVs) carrying important molecules [32,33].”
BackgroundThe role of bioreactors in tissue engineering
Martin, I., Wendt, D., & Heberer, M. (2004) · Trends in Biotechnology · doi:10.1016/j.tibtech.2003.12.001 · Cited by 1,215 · cited 1×
“These dynamic culturing systems allow the biological processes to occur under controlled conditions: temperature, pH, medium flow rate, oxygen supply, and control of nutrient and metabolite exchanges [58,59].”
BackgroundFitch, M. T., & Silver, J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.014 · Cited by 1,007 · cited 1×
“, cellular dysfunction or death, overactivation of immune cells, production of reactive oxygen species or proteoglycans, and glial scar formation) that exacerbate the primary insult [9,10].”
BackgroundXin, H., Li, Y., Cui, Y., Yang, J. J., Zhang, Z. G., & Chopp, M. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.152 · Cited by 984 · cited 1×
“Additionally, Chopp’s lab added evidence about the MSC exosomes’ therapeutic potential, demonstrating that the administration of BM-MSC exosomes 24 h after injury resulted in increased neurogenesis and angiogenesis in the ischemic boundary zone [145].”
BackgroundGlobal prevalence and incidence of traumatic spinal cord injury
Fehlings, M., Singh, A., Tetreault, L., Kalsi-Ryan, S., & Nouri, A. (2014) · Clinical Epidemiology · doi:10.2147/clep.s68889 · Cited by 945
Xin, H., Li, Y., Buller, B., Katakowski, M., Zhang, Y., Wang, X., Shang, X., Zhang, Z. G., & Chopp, M. (2012) · Stem Cells · doi:10.1002/stem.1129 · Cited by 895 · cited 1×
“With this mechanism they are able to modulate the activity of target cells by interacting directly with the cell membrane through an antibody receptor or releasing their biologic content on cell cytoplasm, finally inducing angiogenesis [91,92] and neurite outgrowth [93,94] and regulating inflammatory responses [95,96].”
BackgroundIn Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior
Zomer, A., Maynard, C., Verweij, F. J., Kamermans, A., Schäfer, R., Beerling, E., Schiffelers, R. M., de Wit, E., Berenguer, J., Ellenbroek, S. I. J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.042 · Cited by 869
Stem Cell Paracrine Actions and Tissue Regeneration
Baraniak, P. R., & McDevitt, T. C. (2010) · Regenerative Medicine · doi:10.2217/rme.09.74 · Cited by 843 · cited 1×
“Currently, this definition could be updated since it is known that, beyond soluble factors, the secretome also has the presence of lipids and extracellular vesicles (EVs) carrying important molecules [32,33].”
BackgroundFrom basics to clinical: A comprehensive review on spinal cord injury
Silva, N. A., Sousa, N., Reis, R. L., & Salgado, A. J. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.002 · Cited by 814 · cited 1×
“SCI leads to long-term functional deficits due to the loss of neurons and glial cells, inflammation, and demyelination [18].”
BackgroundSelf-citationTjalsma, H., Bolhuis, A., Jongbloed, J. D. H., Bron, S., & van Dijl, J. M. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.3.515-547.2000 · Cited by 805 · cited 1×
“[29], who defined it as “both the components of machineries for protein secretion and the native secreted proteins”.”
BackgroundDoeppner, T. R., Herz, J., Görgens, A., Schlechter, J., Ludwig, A.-K., Radtke, S., de Miroschedji, K., Horn, P. A., Giebel, B., & Hermann, D. M. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0078 · Cited by 772
Baglio, S. R., Rooijers, K., Koppers-Lalic, D., Verweij, F. J., Pérez Lanzón, M., Zini, N., Naaijkens, B., Perut, F., Niessen, H. W. M., Baldini, N., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0116-z · Cited by 765 · cited 1×
“Moreover, nucleic acids such as mRNAs, microRNAs, and tRNAs present in EVs may potentially target factors involved in stem cell self-renewal and immune-related mechanisms [104].”
BackgroundExosomes: Vehicles of Intercellular Signaling, Biomarkers, and Vectors of Cell Therapy
Kourembanas, S. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071641 · Cited by 761 · cited 1×
“Therefore, EVs carry nucleic acid and proteins in their lumen or in their lipid membrane to mediate intercellular communication [102,103].”
BackgroundZhang, Y., Chopp, M., Meng, Y., Katakowski, M., Xin, H., Mahmood, A., & Xiong, Y. (2015) · Journal of neurosurgery · doi:10.3171/2014.11.jns14770 · Cited by 737
J. Braga Osorio Gomes Salgado, A., L. Goncalves Reis, R., Jorge Carvalho Sousa, N., M. Gimble, J., J. Salgado, A., L. Reis, R., & Sousa, N. (2010) · Current Stem Cell Research & Therapy · doi:10.2174/157488810791268564 · Cited by 615
Self-citationRe-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics
Armstrong, J. P. K., Holme, M. N., & Stevens, M. M. (2017) · ACS Nano · doi:10.1021/acsnano.6b07607 · Cited by 602 · cited 2×
“Additionally, EVs could be chemically and biologically modified to broaden, alter, and/or enhance their therapeutic capability [103,105,110], the engineering of EVs becoming an emerging focus of research.”
BackgroundLiang, X., Zhang, L., Wang, S., Han, Q., & Zhao, R. C. (2016) · Journal of Cell Science · doi:10.1242/jcs.170373 · Cited by 554 · cited 1×
“With this mechanism they are able to modulate the activity of target cells by interacting directly with the cell membrane through an antibody receptor or releasing their biologic content on cell cytoplasm, finally inducing angiogenesis [91,92] and neurite outgrowth [93,94] and regulating inflammatory responses [95,96].”
Background3D Cell Culture: A Review of Current Approaches and Techniques
Haycock, J. W. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-60761-984-0_1 · Cited by 534 · cited 2×
“Furthermore, due to the high number of flasks needed, the risk of variability between flasks, as well as possible contaminations during the process, increases significantly [58].”
BackgroundEpidemiology, aetiology, and management of ischaemic stroke in young adults
Ekker, M. S., Boot, E. M., Singhal, A. B., Tan, K. S., Debette, S., Tuladhar, A. M., & de Leeuw, F.-E. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30233-3 · Cited by 496
(2014) · Dove Medical Press (Taylor and Francis Group) · Cited by 468
Kim, D.-K., Nishida, H., An, S. Y., Shetty, A. K., Bartosh, T. J., & Prockop, D. J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522297113 · Cited by 433
Pathophysiologic Cascades in Ischemic Stroke
Xing, C., Arai, K., Lo, E. H., & Hommel, M. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00839.x · Cited by 416 · cited 2×
“IS is a cerebrovascular disease that results from blood vessel occlusion or damage, leading to the suppression of blood supply and therefore resulting in focal tissue loss and death of endothelial and neuronal cells [132].”
BackgroundRidder, K., Keller, S., Dams, M., Rupp, A.-K., Schlaudraff, J., Del Turco, D., Starmann, J., Macas, J., Karpova, D., Devraj, K., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001874 · Cited by 412
Zhang, Y., Chopp, M., Zhang, Z. G., Katakowski, M., Xin, H., Qu, C., Ali, M., Mahmood, A., & Xiong, Y. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2016.08.003 · Cited by 392
Zhang, R., Liu, Y., Yan, K., Chen, L., Chen, X.-R., Li, P., Chen, F.-F., & Jiang, X.-D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-106 · Cited by 391
BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury
LU, P., JONES, L., & TUSZYNSKI, M. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.09.018 · Cited by 375
Clayton, A., Harris, C. L., Court, J., Mason, M. D., & Morgan, B. P. (2003) · European Journal of Immunology · doi:10.1002/immu.200310028 · Cited by 345
Restorative effects of human neural stem cell grafts on the primate spinal cord
Rosenzweig, E. S., Brock, J. H., Lu, P., Kumamaru, H., Salegio, E. A., Kadoya, K., Weber, J. L., Liang, J. J., Moseanko, R., Hawbecker, S., et al. (2018) · Nature Medicine · doi:10.1038/nm.4502 · Cited by 342 · cited 1×
“In vivo, injecting BM-MSC secretome into the lesion site is reported to promote neuroprotection, leading to reduction of the cystic cavity and preservation of the spinal tracts, leading overall to locomotor recovery of SCI animals [125,126].”
BackgroundMesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?
Teixeira, F. G., Carvalho, M. M., Sousa, N., & Salgado, A. J. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1290-8 · Cited by 330
Self-citationLiu, W., Wang, Y., Gong, F., Rong, Y., Luo, Y., Tang, P., Zhou, Z., Zhou, Z., Xu, T., Jiang, T., et al. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2018.5835 · Cited by 325
Sun, G., Li, G., Li, D., Huang, W., Zhang, R., Zhang, H., Duan, Y., & Wang, B. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.04.006 · Cited by 314 · cited 1×
“[53,84,111,112], IS [113–115], and PD [92,116–118].”
Plant secretome: Unlocking secrets of the secreted proteins
Agrawal, G. K., Jwa, N., Lebrun, M., Job, D., & Rakwal, R. (2010) · PROTEOMICS · doi:10.1002/pmic.200900514 · Cited by 311 · cited 1×
“This definition then evolved to a more elaborated concept by Hathout and Agrawal in which the secretome was defined by the factors that are secreted by a cell, tissue, or organism to the extracellular space under a defined time and conditions [30,31].”
BackgroundExosomes/miRNAs as mediating cell-based therapy of stroke
Xin, H., Li, Y., & Chopp, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00377 · Cited by 297
Diverse roles for VEGF-A in the nervous system
Mackenzie, F., & Ruhrberg, C. (2012) · Development · doi:10.1242/dev.072348 · Cited by 294 · cited 1×
“Importantly, on the nervous system, VEGF could be associated with neurogenesis [65,66], neuromaturation [67], neuroprotection [68,69], and even neuroregeneration [70].”
BackgroundHuang, J.-H., Yin, X.-M., Xu, Y., Xu, C.-C., Lin, X., Ye, F.-B., Cao, Y., & Lin, F.-Y. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2017.5063 · Cited by 292
The interplay between exosomes and autophagy – partners in crime
Xu, J., Camfield, R., & Gorski, S. M. (2018) · Journal of Cell Science · doi:10.1242/jcs.215210 · Cited by 291 · cited 1×
“The cargo transference between different cells allows a rapid alteration in gene expression and control of critical processes and cell functions [109].”
BackgroundMSCs-Derived Exosomes: Cell-Secreted Nanovesicles with Regenerative Potential
Marote, A., Teixeira, F. G., Mendes-Pinheiro, B., & Salgado, A. J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00231 · Cited by 290 · cited 1×
“Exosomes are drawing the attention of the regenerative medicine field because of their therapeutic potential for CNS regeneration [97,98].”
BackgroundSelf-citationChang, C.-P., Chio, C.-C., Cheong, C.-U., Chao, C.-M., Cheng, B.-C., & Lin, M.-T. (2013) · Clinical Science · doi:10.1042/cs20120226 · Cited by 287 · cited 1×
“In pathologies related to the CNS, using the secretome of cells preconditioned by hypoxia in a rat model of TBI led to a significantly better performance both in motor and cognitive tests together with minor brain damage when compared with normoxic-secretome [46].”
BackgroundFibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration
Woodbury, M. E., & Ikezu, T. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9501-5 · Cited by 266 · cited 1×
“Importantly, FGF is crucial during CNS development and therefore it may also play an essential role in neurodegenerative disorders [79].”
BackgroundConsidering the evolution of regeneration in the central nervous system
Tanaka, E. M., & Ferretti, P. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2707 · Cited by 264 · cited 1×
“Although having different aetiology, symptomatology, and pathophysiology, CNS injuries and disorders are in part challenging due to a shared feature—the low regenerative capacity of the adult CNS [5,6].”
BackgroundChen, L., Xu, Y., Zhao, J., Zhang, Z., Yang, R., Xie, J., Liu, X., & Qi, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096161 · Cited by 251
MSCs-Derived Exosomes and Neuroinflammation, Neurogenesis and Therapy of Traumatic Brain Injury
Yang, Y., Ye, Y., Su, X., He, J., Bai, W., & He, X. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00055 · Cited by 236
Pires, A. O., Mendes-Pinheiro, B., Teixeira, F. G., Anjo, S. I., Ribeiro-Samy, S., Gomes, E. D., Serra, S. C., Silva, N. A., Manadas, B., Sousa, N., et al. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0048 · Cited by 235 · cited 2×
“Indeed, it is known that the secretome from the different MSC sources contains a soluble fraction rich in pro- and anti-inflammatory cytokines, extracellular matrix proteins, neuroprotective and neurodifferentiation agents, or even neurite growth factors [37,87], as briefly”
BackgroundSelf-citationVella, L., Hill, A., & Cheng, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020173 · Cited by 230
Exosomes in stroke pathogenesis and therapy
Zhang, Z. G., & Chopp, M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81133 · Cited by 225
Cantinieaux, D., Quertainmont, R., Blacher, S., Rossi, L., Wanet, T., Noël, A., Brook, G., Schoenen, J., & Franzen, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069515 · Cited by 223
Smith, C. M., Jerkovic, A., Truong, T. T., Foote, S. J., McCarthy, J. S., & McMorran, B. J. (2017) · Scientific Reports · doi:10.1038/srep41975 · Cited by 219
Osaka, M., Honmou, O., Murakami, T., Nonaka, T., Houkin, K., Hamada, H., & Kocsis, J. D. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.011 · Cited by 218
Zhang, Z., Yang, D., Zhang, M., Zhu, N., Zhou, Y., Storm, D. R., & Wang, Z. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00001 · Cited by 218
Quertainmont, R., Cantinieaux, D., Botman, O., Sid, S., Schoenen, J., & Franzen, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039500 · Cited by 217 · cited 1×
“A study using MSC transplantation in an SCI model also supported this observation as no MSCs were found within the host tissue, but an increase in factors such as NGF could instead be observed [120].”
ResultLankford, K. L., Arroyo, E. J., Nazimek, K., Bryniarski, K., Askenase, P. W., & Kocsis, J. D. (2018) · PLOS ONE · doi:10.1371/journal.pone.0190358 · Cited by 215 · cited 1×
“With this mechanism they are able to modulate the activity of target cells by interacting directly with the cell membrane through an antibody receptor or releasing their biologic content on cell cytoplasm, finally inducing angiogenesis [91,92] and neurite outgrowth [93,94] and regulating inflammatory responses [95,96].”
BackgroundLee, M. J., Kim, J., Kim, M. Y., Bae, Y.-S., Ryu, S. H., Lee, T. G., & Kim, J. H. (2010) · Journal of Proteome Research · doi:10.1021/pr900898n · Cited by 209
Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth
Lopez-Verrilli, M. A., Caviedes, A., Cabrera, A., Sandoval, S., Wyneken, U., & Khoury, M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.01.061 · Cited by 207 · cited 1×
“With this mechanism they are able to modulate the activity of target cells by interacting directly with the cell membrane through an antibody receptor or releasing their biologic content on cell cytoplasm, finally inducing angiogenesis [91,92] and neurite outgrowth [93,94] and regulating inflammatory responses [95,96].”
BackgroundTeixeira, F. G., Carvalho, M. M., Panchalingam, K. M., Rodrigues, A. J., Mendes-Pinheiro, B., Anjo, S., Manadas, B., Behie, L. A., Sousa, N., & Salgado, A. J. (2017) · Stem Cells Translational Medicine · doi:10.5966/sctm.2016-0071 · Cited by 204 · cited 4×
“For instance, it has been demonstrated that the beneficial effects observed upon mesenchymal stem cell (MSC) grafts on the injured CNS were mainly due to secreted factors rather than cellular engraftment, in models of spinal cord injury [14] and Parkinson’s disease [17], as reviewed elsewhere [18–20].”
BackgroundSelf-citationApproaches to the study of the cell secretome
Hathout, Y. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.2.239 · Cited by 203 · cited 1×
“This definition then evolved to a more elaborated concept by Hathout and Agrawal in which the secretome was defined by the factors that are secreted by a cell, tissue, or organism to the extracellular space under a defined time and conditions [30,31].”
BackgroundMesenchymal Stem Cell Transplantation Attenuates Brain Injury After Neonatal Stroke
van Velthoven, C. T. J., Sheldon, R. A., Kavelaars, A., Derugin, N., Vexler, Z. S., Willemen, H. L. D. M., Maas, M., Heijnen, C. J., & Ferriero, D. M. (2013) · Stroke · doi:10.1161/strokeaha.111.000326 · Cited by 201
Heo, S. C., Jeon, E. S., Lee, I. H., Kim, H. S., Kim, M. B., & Kim, J. H. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.64 · Cited by 197 · cited 1×
“, who also observed beneficial effects on wound healing, angiogenesis, and immune cell infiltration due to those cytokines [48].”
BackgroundOtero-Ortega, L., Laso-García, F., Gómez-de Frutos, M. D. C., Rodríguez-Frutos, B., Pascual-Guerra, J., Fuentes, B., Díez-Tejedor, E., & Gutiérrez-Fernández, M. (2017) · Scientific Reports · doi:10.1038/srep44433 · Cited by 195
Focus on Mesenchymal Stem Cell-Derived Exosomes: Opportunities and Challenges in Cell-Free Therapy
Cheng, L., Zhang, K., Wu, S., Cui, M., & Xu, T. (2017) · Stem Cells International · doi:10.1155/2017/6305295 · Cited by 191 · cited 2×
“Additionally, EVs could be chemically and biologically modified to broaden, alter, and/or enhance their therapeutic capability [103,105,110], the engineering of EVs becoming an emerging focus of research.”
BackgroundKim, H. Y., Kumar, H., Jo, M.-J., Kim, J., Yoon, J.-K., Lee, J.-R., Kang, M., Choo, Y. W., Song, S. Y., Kwon, S. P., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01816 · Cited by 190 · cited 1×
“[53,84,111,112], IS [113–115], and PD [92,116–118].”
Wang, L., Pei, S., Han, L., Guo, B., Li, Y., Duan, R., Yao, Y., Xue, B., Chen, X., & Jia, Y. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000494652 · Cited by 187 · cited 1×
“Additionally, an intravenous injection of MSCs or MSC-derived exosomes in an SCI context revealed a comparable therapeutic effect [130].”
BackgroundCritical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo
Kato, N., Matsumoto, M., Kogawa, M., Atkins, G. J., Findlay, D. M., Fujikawa, T., Oda, H., & Ogata, M. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-1 · Cited by 180
Chen, Q., Long, Y., Yuan, X., Zou, L., Sun, J., Chen, S., Perez‐Polo, J. R., & Yang, K. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20494 · Cited by 178 · cited 1×
“Several factors secreted by MSCs such as NGF, GDNF, BDNF, and Wnt3a could attenuate the loss of cholinergic neurons in the medial septum of mice and still promote hippocampal neurogenesis [136,137].”
BackgroundChen, L., Xu, Y., Zhao, J., Zhang, Z., Yang, R., Xie, J., Liu, X., & Qi, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145565 · Cited by 174
Herrmann, J. L., Wang, Y., Abarbanell, A. M., Weil, B. R., Tan, J., & Meldrum, D. R. (2010) · Shock · doi:10.1097/shk.0b013e3181b7d137 · Cited by 170 · cited 1×
“Furthermore, TNF-α seems to be a potent inducer of VEGF production in MSCs [49,50].”
BackgroundMesenchymal stem cells for the sustained in vivo delivery of bioactive factors
Meyerrose, T., Olson, S., Pontow, S., Kalomoiris, S., Jung, Y., Annett, G., Bauer, G., & Nolta, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.013 · Cited by 169 · cited 1×
“Indeed, factors such as GDNF, NGF, HGF, VEGF, IGF-1 and 2, chemokine (C-X-C motif) ligand (CXCL 16), IL-6 and 10, TGF β1, and MCP-1 have been related to the neuro- and immunoregulatory character of MSC secretome [63,87,99,100].”
BackgroundBai, Y., Han, Y.-D., Yan, X.-L., Ren, J., Zeng, Q., Li, X.-D., Pei, X.-T., & Han, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.065 · Cited by 168 · cited 12×
“The therapeutic potential of EVs has received the attention of researchers in the field of CNS pathologies such as SCI [53,84,111,112], IS [113–115], and PD [92,116–118].”
BackgroundInfluentialEmerging potential of exosomes for treatment of traumatic brain injury
Xiong, Y., Mahmood, A., & Chopp, M. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.198966 · Cited by 165
Han, Y.-D., Bai, Y., Yan, X., Ren, J., Zeng, Q., Li, X., Pei, X., & Han, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.076 · Cited by 165
Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review
Panchalingam, K. M., Jung, S., Rosenberg, L., & Behie, L. A. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0228-5 · Cited by 163 · cited 1×
“Moreover, they allow the expansion to a high number of cells in one vessel with consequent higher secretome production compared with traditional systems [60].”
BackgroundUnderstanding extracellular vesicle diversity – current status
Greening, D. W., & Simpson, R. J. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1537788 · Cited by 160 · cited 1×
“On the other hand, they also present a vesicular fraction, composed of exosomes, microvesicles, and apoptotic bodies [88].”
BackgroundVilaça-Faria, H., Salgado, A. J., & Teixeira, F. G. (2019) · Cells · doi:10.3390/cells8020118 · Cited by 152
Self-citationGuan, J., Zhu, Z., Zhao, R. C., Xiao, Z., Wu, C., Han, Q., Chen, L., Tong, W., Zhang, J. C., Han, Q., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.047 · Cited by 152
Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic Systems
Ohno, S.-I., Drummen, G., & Kuroda, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020172 · Cited by 152 · cited 1×
“Additionally, EVs could be chemically and biologically modified to broaden, alter, and/or enhance their therapeutic capability [103,105,110], the engineering of EVs becoming an emerging focus of research.”
BackgroundKiyota, T., Ingraham, K. L., Jacobsen, M. T., Xiong, H., & Ikezu, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102349108 · Cited by 145 · cited 1×
“Indeed, the possible manipulation of FGF2/FGFR1 offers therapeutic opportunities for Alzheimer’s [80] and Parkinson’s diseases [81].”
BackgroundStem cells: a promising candidate to treat neurological disorders
Zheng, M.-H., Han, H., Song, C.-G., Zhang, Y.-Z., Wu, H.-N., Cao, X.-L., Guo, C.-J., & Li, Y.-Q. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.235085 · Cited by 138 · cited 1×
“Several cellular types have already been tested in a broad number of models of CNS disorders aiming to repopulate the damaged tissue or minimize the secondary impacts of each pathology [16].”
BackgroundShort-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells
Antebi, B., Rodriguez, L. A., Walker, K. P., Asher, A. M., Kamucheka, R. M., Alvarado, L., Mohammadipoor, A., & Cancio, L. C. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1007-x · Cited by 137
Oses, C., Olivares, B., Ezquer, M., Acosta, C., Bosch, P., Donoso, M., Léniz, P., & Ezquer, F. (2017) · PLOS ONE · doi:10.1371/journal.pone.0178011 · Cited by 137 · cited 1×
“Improvements in the secretome of ASCs was also observed increasing the secretion of proangiogenic, neuroprotective, and anti-inflammatory molecules and increasing the antioxidant capacity of their secretome when preconditioned with deferoxamine [56].”
BackgroundRibeiro, C. A., Fraga, J. S., Grãos, M., Neves, N. M., Reis, R. L., Gimble, J. M., Sousa, N., & Salgado, A. J. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt109 · Cited by 130
Self-citationTimmer, M., Cesnulevicius, K., Winkler, C., Kolb, J., Lipokatic-Takacs, E., Jungnickel, J., & Grothe, C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4493-06.2007 · Cited by 126 · cited 1×
“Indeed, the possible manipulation of FGF2/FGFR1 offers therapeutic opportunities for Alzheimer’s [80] and Parkinson’s diseases [81].”
BackgroundMussano, F., Genova, T., Corsalini, M., Schierano, G., Pettini, F., Di Venere, D., & Carossa, S. (2017) · Stem Cells International · doi:10.1155/2017/6202783 · Cited by 125 · cited 1×
“This information is based on the articles [85,86].”
BackgroundVEGF-B selectively regenerates injured peripheral neurons and restores sensory and trophic functions
Guaiquil, V. H., Pan, Z., Karagianni, N., Fukuoka, S., Alegre, G., & Rosenblatt, M. I. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407227111 · Cited by 120 · cited 11×
“The therapeutic potential of EVs has received the attention of researchers in the field of CNS pathologies such as SCI [53,84,111,112], IS [113–115], and PD [92,116–118].”
BackgroundInfluentialThe role of exosomes in CNS inflammation and their involvement in multiple sclerosis
Selmaj, I., Mycko, M. P., Raine, C. S., & Selmaj, K. W. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.02.002 · Cited by 119 · cited 1×
“With this mechanism they are able to modulate the activity of target cells by interacting directly with the cell membrane through an antibody receptor or releasing their biologic content on cell cytoplasm, finally inducing angiogenesis [91,92] and neurite outgrowth [93,94] and regulating inflammatory responses [95,96].”
BackgroundTeixeira, F. G., Carvalho, M. M., Neves‐Carvalho, A., Panchalingam, K. M., Behie, L. A., Pinto, L., Sousa, N., & Salgado, A. J. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9576-2 · Cited by 118 · cited 5×
“Moreover, Salgado and coworkers [82] pointed out that the secretome from WJ-MSCs and HUCPVCs is also able to increase survival, proliferation, and differentiation of hippocampal neurons due to the presence of, for example, NGF and FGF [82,83].”
BackgroundSelf-citationLee, J. Y., Kim, E., Choi, S.-M., Kim, D.-W., Kim, K. P., Lee, I., & Kim, H.-S. (2016) · Scientific Reports · doi:10.1038/srep33038 · Cited by 115
Vascular endothelial growth factor promotes neurite maturation in primary CNS neuronal cultures
Khaibullina, A. A., Rosenstein, J. M., & Krum, J. M. (2004) · Developmental Brain Research · doi:10.1016/j.devbrainres.2003.09.022 · Cited by 114 · cited 2×
“This effect occurs through VEGF receptor and MAPK/Erk1/2 signal transduction pathways which are mediating the growth effects on CNS neurons [68].”
BackgroundJeong, S. R., Kwon, M. J., Lee, H. G., Joe, E. H., Lee, J. H., Kim, S., Suh‐Kim, H., & Kim, B. G. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.10.021 · Cited by 112
Teixeira, F. G., Panchalingam, K. M., Assunção-Silva, R., Serra, S. C., Mendes-Pinheiro, B., Patrício, P., Jung, S., Anjo, S. I., Manadas, B., Pinto, L., et al. (2016) · Scientific Reports · doi:10.1038/srep27791 · Cited by 112 · cited 1×
“demonstrated that human bone marrow (hBM)-MSCs expanded in bioreactors improve differentiation of human neural progenitor cells (hNPCs) to neurons when compared with secretome from static cultures in vitro [61].”
BackgroundSelf-citationZhou, X., Chu, X., Yuan, H., Qiu, J., Zhao, C., Xin, D., Li, T., Ma, W., Wang, H., Wang, Z., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108818 · Cited by 111
Mesenchymal Stem Cells Modulate the Functional Properties of Microglia via TGF-β Secretion
Noh, M. Y., Lim, S. M., Oh, K.-W., Cho, K.-A., Park, J., Kim, K.-S., Lee, S.-J., Kwon, M.-S., & Kim, S. H. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0217 · Cited by 110
Revilla, S., Ursulet, S., Álvarez‐López, M. J., Castro‐Freire, M., Perpiñá, U., García‐Mesa, Y., Bortolozzi, A., Giménez‐Llort, L., Kaliman, P., Cristòfol, R., et al. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12312 · Cited by 109
STAT3 mediates bone marrow mesenchymal stem cell VEGF production
Wang, M., Zhang, W., Crisostomo, P. R., Markel, T. A., Meldrum, K. K., Fu, X. Y., & Meldrum, D. R. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.04.010 · Cited by 108 · cited 1×
“Furthermore, TNF-α seems to be a potent inducer of VEGF production in MSCs [49,50].”
BackgroundHan, Y., Seyfried, D., Meng, Y., Yang, D., Schultz, L., Chopp, M., & Seyfried, D. (2018) · Journal of Neurosurgery · doi:10.3171/2018.2.jns171475 · Cited by 105
Oxygen Tension Regulates Human Mesenchymal Stem Cell Paracrine Functions
Paquet, J., Deschepper, M., Moya, A., Logeart-Avramoglou, D., Boisson-Vidal, C., & Petite, H. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0180 · Cited by 102
Transplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke
Wang, F., Tang, H., Zhu, J., & Zhang, J. H. (2018) · Cell Transplantation · doi:10.1177/0963689718795424 · Cited by 102
Old and new challenges in Parkinson's disease therapeutics
Pires, A. O., Teixeira, F. G., Mendes-Pinheiro, B., Serra, S. C., Sousa, N., & Salgado, A. J. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.04.006 · Cited by 99
Self-citationMesenchymal stem cells secretome-induced axonal outgrowth is mediated by BDNF
Martins, L. F., Costa, R. O., Pedro, J. R., Aguiar, P., Serra, S. C., Teixeira, F. G., Sousa, N., Salgado, A. J., & Almeida, R. D. (2017) · Scientific Reports · doi:10.1038/s41598-017-03592-1 · Cited by 96 · cited 12×
“The therapeutic potential of EVs has received the attention of researchers in the field of CNS pathologies such as SCI [53,84,111,112], IS [113–115], and PD [92,116–118].”
BackgroundSelf-citationWalker, P. A., Harting, M. T., Jiménez, F., Shah, S. K., Pati, S., Dash, P. K., & Cox, C. S. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0188 · Cited by 91
Elucidating Diversity of Exosomes: Biophysical and Molecular Characterization Methods
Khatun, Z., Bhat, A., Sharma, S., & Sharma, A. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0192 · Cited by 91 · cited 3×
“, messenger RNAs and microRNAs) and small proteins are secreted through membranal fusion to the extracellular space [89,90].”
BackgroundGiacoppo, S., Rajan, T. S., Diomede, F., Bramanti, P., Conti, P., Trubiani, O., & Mazzon, E. (2017) · The FASEB Journal · doi:10.1096/fj.201700524r · Cited by 88
Xu, P., & Yang, X. (2018) · Cell Transplantation · doi:10.1177/0963689718808471 · Cited by 88
Gomes, E. D., Mendes, S., Leite‐Almeida, H., Gimble, J. M., Tam, R. Y., Shoichet, M. S., Sousa, N., Silva, N. A., & Salgado, A. J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.07.019 · Cited by 85 · cited 1×
“Candidate novel therapies have emerged in the CNS regeneration context, such as molecular therapies [11,12], biomaterials [13], and cellular transplantation [14–16].”
BackgroundSelf-citationZhao, Y., Gibb, S. L., Zhao, J., Moore, A. N., Hylin, M. J., Menge, T. D., Xue, H., Baimukanova, G., Potter, D. R., Johnson, E. M., et al. (2016) · Stem Cells · doi:10.1002/stem.2310 · Cited by 83 · cited 1×
“Several factors secreted by MSCs such as NGF, GDNF, BDNF, and Wnt3a could attenuate the loss of cholinergic neurons in the medial septum of mice and still promote hippocampal neurogenesis [136,137].”
BackgroundLee, S. C., Jeong, H. J., Lee, S. K., & Kim, S.-J. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0072-7 · Cited by 82 · cited 1×
“It is also known that lipopolysaccharide preconditioning of ASCs increases the levels of the immunomodulators TNF-α and IL-6 as well as increasing the regenerative profile [51] of secretome.”
BackgroundSevivas, N., Teixeira, F. G., Portugal, R., Araújo, L., Carriço, L. F., Ferreira, N., Vieira da Silva, M., Espregueira-Mendes, J., Anjo, S., Manadas, B., et al. (2017) · The American Journal of Sports Medicine · doi:10.1177/0363546516657827 · Cited by 80 · cited 1×
“After the conditioned period, only the factors released by the cells (secretome/conditioned media (CM)) are collected and stored at −80◦C after being snap-frozen to maintain its biological properties [17,35,36].”
BackgroundSelf-citationHuang, W., Lv, B., Zeng, H., Shi, D., Liu, Y. F., Chen, F., Li, F., Liu, X., Zhu, R., Yu, L., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24981 · Cited by 80 · cited 1×
“The application of MSC secretome in this context revealed also that the factors released by these cells such as IGF-α and BDNF could promote neuroprotection, by blocking neuronal damage and tissue loss [144].”
BackgroundXu, C., Fu, F., Li, X., & Zhang, S. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1325884 · Cited by 74
Assunção-Silva, R. C., Mendes-Pinheiro, B., Patrício, P., Behie, L. A., Teixeira, F. G., Pinto, L., & Salgado, A. J. (2018) · Biochimie · doi:10.1016/j.biochi.2018.07.026 · Cited by 73 · cited 1×
“This information is based on the articles [85,86].”
BackgroundSelf-citationMendes-Pinheiro, B., Teixeira, F. G., Anjo, S. I., Manadas, B., Behie, L. A., & Salgado, A. J. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0009 · Cited by 73 · cited 1×
“have shown that, in fact, secretome-based therapies could be more efficient than their cell transplant counterparts, in a similar model of PD [149].”
ResultSelf-citationXia, X., Chiu, P. W. Y., Lam, P. K., Chin, W., Ng, E. K., & Lau, J. Y. W. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.009 · Cited by 71
Park, H., Park, H., Mun, D., Kang, J., Kim, H., Kim, M., Cui, S., Lee, S.-H., & Joung, B. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2018.59.6.736 · Cited by 70 · cited 1×
“In other injury scenarios, this preconditioning method of MSCs seems to potentiate the wound healing and regenerative process provided by the secretome [41–43] when delivering the total secretome or only the vesicular fraction [44,45].”
MethodAttenuating Spinal Cord Injury by Conditioned Medium from Bone Marrow Mesenchymal Stem Cells
Tsai, M., Liou, D.-Y., Lin, Y.-R., Weng, C., Huang, M., Huang, W., Tseng, F.-W., & Cheng, H. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm8010023 · Cited by 70 · cited 1×
“In vivo, injecting BM-MSC secretome into the lesion site is reported to promote neuroprotection, leading to reduction of the cystic cavity and preservation of the spinal tracts, leading overall to locomotor recovery of SCI animals [125,126].”
BackgroundExosomes: A New Weapon to Treat the Central Nervous System
Braccioli, L., van Velthoven, C. T. J., & Heijnen, C. J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8504-9 · Cited by 69 · cited 2×
“Indeed, the administration of MSC-derived exosomes could restore tissue function in multiple disease/injury models [97].”
BackgroundAly, A. E.-E., Harmon, B. T., Padegimas, L., Sesenoglu‐Laird, O., Cooper, M. J., & Waszczak, B. L. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1109-6 · Cited by 69
Lima, R., Monteiro, S., Lopes, J., Barradas, P. S., Vasconcelos, N., Gomes, E. D., Assunção-Silva, R. C., Teixeira, F. G., Morais, M., Sousa, N., et al. (2017) · Pharmaceuticals · doi:10.3390/ph10040083 · Cited by 66 · cited 1×
“Candidate novel therapies have emerged in the CNS regeneration context, such as molecular therapies [11,12], biomaterials [13], and cellular transplantation [14–16].”
BackgroundSelf-citationGuillén, M. I., Platas, J., Pérez del Caz, M. D., Mirabet, V., & Alcaraz, M. J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00661 · Cited by 65 · cited 1×
“More specifically, secretome from ASCs reduced the production of TNF-α by M1 macrophages while enhancing TGF β1 and IL-10 release by M2 macrophages [124].”
BackgroundCentral nervous system regeneration does not occur
Illis, L. S. (2011) · Spinal Cord · doi:10.1038/sc.2011.132 · Cited by 65 · cited 1×
“Although having different aetiology, symptomatology, and pathophysiology, CNS injuries and disorders are in part challenging due to a shared feature—the low regenerative capacity of the adult CNS [5,6].”
BackgroundKhalili, M., Anbari, F., Bahrami, A. R., Khoradmehr, A., Sadeghian‐Nodoushan, F., Fesahat, F., & Nabi, A. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.133133 · Cited by 65 · cited 8×
“TBI is characterized by external mechanical forces causing brain injury, which potentially cause physical, cognitive, and emotional impairments to the patients [131,132].”
BackgroundInfluentialOh, S. H., Kim, H. N., Park, H. J., Shin, J. Y., Kim, D. Y., & Lee, P. H. (2017) · Stem Cells Translational Medicine · doi:10.5966/sctm.2016-0111 · Cited by 65 · cited 1×
“showing that the secretome from MSCs can reduce the α-synuclein aggregates, one of the hallmarks of the disease, through an MMP-2-based mechanism [150].”
BackgroundJinesh G., G., Chunduru, S., & Kamat, A. M. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1211623 · Cited by 60
Gomes, E. D., Mendes, S. S., Assunção-Silva, R. C., Teixeira, F. G., Pires, A. O., Anjo, S. I., Manadas, B., Leite-Almeida, H., Gimble, J. M., Sousa, N., et al. (2018) · Stem Cells · doi:10.1002/stem.2785 · Cited by 57 · cited 2×
“Different studies point to the secreted factors and vesicles—their secretome—as agents for the regenerative effect rather than cellular differentiation [14].”
BackgroundSelf-citationLiu, X., Wei, M., Liang, J., Xu, H., Wang, J., Wang, J., Yang, X., Lv, F., Wang, K., Duan, J., et al. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14859 · Cited by 55 · cited 1×
“In a case of TBI, the traumatic injury-preconditioned secretome increased the differentiation, migration, and maturation of new-born cells, improving the cognitive function after the trauma [57].”
BackgroundLi, J., Chen, S., Zhao, Z., Luo, Y., Hou, Y., Li, H., He, L., Zhou, L., & Wu, W. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00381 · Cited by 48 · cited 1×
“Among currently known neurotrophic factors, GDNF has the most pronounced neuroprotective effect, which is particularly relevant in ischemic brain damage [72,73] and neurodegenerative diseases [74–76].”
BackgroundTherapeutic angiogenesis of exosomes for ischemic stroke.
Manuel, G., Johnson, T. K., & Liu, D. (2017) · PubMed · Cited by 46
Salgado, A. J., Fraga, J. S., Mesquita, A. R., Neves, N. M., Reis, R. L., & Sousa, N. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0279 · Cited by 45 · cited 5×
“Moreover, Salgado and coworkers [82] pointed out that the secretome from WJ-MSCs and HUCPVCs is also able to increase survival, proliferation, and differentiation of hippocampal neurons due to the presence of, for example, NGF and FGF [82,83].”
BackgroundSelf-citationProspects and Limitations of Using Endogenous Neural Stem Cells for Brain Regeneration
Kaneko, N., Kako, E., & Sawamoto, K. (2011) · Genes · doi:10.3390/genes2010107 · Cited by 45 · cited 1×
“These cells can be found in the adult CNS, however only in specific small niches and in limited numbers, resulting in a low regenerative ability for fully repairing damaged tissue [8].”
BackgroundVasconcelos, N. L., Gomes, E. D., Oliveira, E. P., da Silva, C. J., Lima, R., Sousa, N., Salgado, A. J., & Silva, N. A. (2016) · The Spine Journal · doi:10.1016/j.spinee.2016.04.013 · Cited by 38 · cited 1×
“Candidate novel therapies have emerged in the CNS regeneration context, such as molecular therapies [11,12], biomaterials [13], and cellular transplantation [14–16].”
BackgroundSelf-citationMitroshina, Е. V., Mishchenko, T. A., Shirokova, O. M., Astrakhanova, T. A., Loginova, M. M., Epifanova, E. A., Babaev, A. A., Tarabykin, V. S., & Vedunova, M. V. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/1036907 · Cited by 37 · cited 1×
“Additionally, by binding to their main receptor (GRFα), GDNF activates several intracellular signaling cascades such as Ras/MAPK and PI3K/Akt, which can suppress pro-apoptotic proteins (p53) and caspases (caspase 3 and 9), promoting neural survival [78].”
BackgroundMuniswami, D. M., Kanthakumar, P., Kanakasabapathy, I., & Tharion, G. (2018) · Annals of Neurosciences · doi:10.1159/000487069 · Cited by 34
Zavala, G., Prieto, C. P., Villanueva, A., & Palma, V. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0653-8 · Cited by 32
Uçar, B., & Humpel, C. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.04.012 · Cited by 32 · cited 1×
“the neuron–glia networks and their functional structure [77].”
BackgroundQi, L., Xue, X., Sun, J., Wu, Q., Wang, H., Guo, Y., & Sun, B. (2018) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000005042 · Cited by 29 · cited 8×
“TBI is characterized by external mechanical forces causing brain injury, which potentially cause physical, cognitive, and emotional impairments to the patients [131,132].”
BackgroundInfluentialVEGF protects human cerebral hybrid neurons from in vitro ischemia
Han, M., Kim, M., Bae, S. Y., Kang, L., Han, S. Y., Lee, Y., Rha, J. H., Kim, S. U., & Roh, J. (2004) · Neuroreport · doi:10.1097/00001756-200404090-00022 · Cited by 27 · cited 2×
“As such, VEGF fosters the reorganization of the spinal motor network after SCI [71] and also underlies a protective effect against ischemia [69].”
BackgroundChoi, Y., Urnukhsaikhan, E., Yoon, H., Seo, Y., & Park, J. (2016) · Biotechnology Journal · doi:10.1002/biot.201600057 · Cited by 27
Shishkina, T. V., Mishchenko, T. A., Mitroshina, Е. V., Shirokova, O. M., Pimashkin, A. S., Kastalskiy, I. A., Mukhina, I. V., Kazantsev, V., & Vedunova, M. V. (2017) · Brain Research · doi:10.1016/j.brainres.2017.10.023 · Cited by 27
Intravenous PEP-1-GDNF is protective after focal cerebral ischemia in rats
Liu, Y., Wang, S.-W., Luo, S., Li, Q., Liang, F., Zhu, Y., Pei, Z., & Huang, R. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.017 · Cited by 25 · cited 2×
“Among currently known neurotrophic factors, GDNF has the most pronounced neuroprotective effect, which is particularly relevant in ischemic brain damage [72,73] and neurodegenerative diseases [74–76].”
BackgroundIschemic tolerance is associated with VEGF-C and VEGFR-3 signaling in the mouse hippocampus
Bhuiyan, M. I. H., KIM, J.-C., Hwang, S.-N., Lee, M.-Y., & Kim, S.-Y. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.025 · Cited by 23 · cited 1×
“Importantly, on the nervous system, VEGF could be associated with neurogenesis [65,66], neuromaturation [67], neuroprotection [68,69], and even neuroregeneration [70].”
BackgroundUnraveling Mesenchymal Stem Cells’ Dynamic Secretome Through Nontargeted Proteomics Profiling
Anjo, S. I., Lourenço, A. S., Melo, M. N., Santa, C., & Manadas, B. J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3584-0_32 · Cited by 22 · cited 2×
“In order to fill those gaps, methods to characterize the secretome composition are already available as is the case of non-target proteomic analysis, which allows researchers to have a wide detection ability and potentially detect any protein present in the secretome [62].”
BackgroundMethodHong, H.-E., Kim, O.-H., Kwak, B. J., Choi, H. J., im, K.-H., Ahn, J., & Kim, S.-J. (2019) · Annals of Surgical Treatment and Research · doi:10.4174/astr.2019.97.4.159 · Cited by 21 · cited 1×
“In non-CNS-related pathologies, secretome preconditioned in hypoxia from adipose stem cells (ASCs) is reported to improve recovery in a model of hepatic injury in both in vitro and in vivo, with upper regulation of enzymes with antioxidant properties [40].”
BackgroundCastro, B., Martinez-Redondo, D., Gartzia, I., Alonso‐Varona, A., Garrido, P., & Palomares, T. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2797 · Cited by 20
Jahandideh, S., Maghsood, F., Ghahhari, N. M., Lotfinia, M., Mohammadi, M., Johari, B., & Kadivar, M. (2017) · Tissue and Cell · doi:10.1016/j.tice.2017.08.003 · Cited by 12 · cited 3×
“However, under oxygen deprivation, the MSCs alter their secretome properties, enhancing the production of chemoattractant factors (interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), RANTES, granulocyte-macrophage colony-stimulating factor (GM-CSF) and angiogenic mediators (angiogenin, matrix metalloprot…”
BackgroundEndogenous Neural stem Cells and Neurological Disorders
Rayate, M. (2017) · Open access Journal of Neurology & Neurosurgery · doi:10.19080/oajnn.2017.04.555627 · Cited by 1 · cited 1×
“Self and spontaneous repair of the CNS can eventually occur, although at a small scale, through the action of endogenous neural stem cells [7].”
Background
Research works printed but not linked: 1
- Chang, 2013, Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury, Clin. Sci., 124, 165, 10.1042/cs20120226 · DOI · Paper page
Cited by
Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?
Trigo, C. M., Rodrigues, J. S., Camões, S. P., Solá, S., & Miranda, J. P. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2024.05.004 · Cited by 252
“…have an important role in mediating the regenerative and immunomodulatory properties of MSCs [51,52], a completely consensus is not established [53,54], with some data showing that the total MSC-secretome and MSC-EV-free fraction had better immunomodulatory effects when compared with MSC-EVs…”
InfluentialDental Pulp Stem Cell-Derived Secretome and Its Regenerative Potential
Bar, J. K., Lis-Nawara, A., & Grelewski, P. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112018 · Cited by 142
Pathophysiology and Therapeutic Approaches for Spinal Cord Injury
Lima, R., Monteiro, A., Salgado, A. J., Monteiro, S., & Silva, N. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213833 · Cited by 142
Self-citationZhou, X., Chu, X., Yuan, H., Qiu, J., Zhao, C., Xin, D., Li, T., Ma, W., Wang, H., Wang, Z., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108818 · Cited by 111
Mesenchymal Stem Cell-Based Therapy for Stroke: Current Understanding and Challenges
Li, W., Shi, L., Hu, B., Hong, Y., Zhang, H., Li, X., & Zhang, Y. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.628940 · Cited by 115
“They can be isolated from almost all tissues in mammals including bone marrow (BM), adipose tissue or other tissues (Pinho et al., 2020) and are easy to culture and effectively expand.”
Background
Metadata
- Authors
- Pinho, A. G., Cibrão, J. R., Silva, N. A., Monteiro, S., & Salgado, A. J.
- Affiliations
- University of Minho (PT)
- Corresponding author
- Salgado, António J.
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2020-02-20
- Volume
- 13
- Issue
- 2
- Pages
- 31
- ISSN
- 1424-8247 (ISSN-L)
- PMC
- PMC7169381
- OpenAlex
- W3007972554
- Cited by
- 94
- References
- 155
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 18 · 2023: 15 · 2022: 17 · 2021: 12 · 2020: 5
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pharmaceuticals (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-nc-nd)
- Funders
- FUNDAÇÃO PARA A CIÊNCIA E TECNOLOGIA, SANTA CASA NEUROSCIENCE AWARDS, NORTE 2020, FEDER, COMPETE (MC-04/17; CEECIND/04794/2017; CEECIND/01902/2017; POCI-01-0145-FEDER-007038; TUBITAK/0007/2014; POCI-01-0145-FEDER-029206, POCI-01-0145-FEDER-029751; NORTE-01-0145-FEDER-029968; NORTE-01-0145-FEDER-000013 and NORTE-01-0145-FEDER-000023)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Keywords
- secretome, mesenchymal stem cells, cell transplantation, extracellular vesicles, spinal cord injury, traumatic brain injury, ischemic stroke, Parkinson's disease, central nervous system disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.